Argitalpenak (99) FRANCISCO GALEANO VALLE argitalpenak

2024

  1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

  2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

  3. Comparative analysis of COVID-19-associated venous thromboembolism outcomes: evolution from 2020 to 2021–2022

    Journal of Thrombosis and Thrombolysis, Vol. 57, Núm. 7, pp. 1239-1248

  4. Evaluation of soluble P-selectin as a predictive biomarker in acute symptomatic pulmonary embolism: Insights from a prospective observational study

    European Journal of Haematology, Vol. 113, Núm. 2, pp. 201-207

  5. External validation of a prognostic score to identify low-risk outpatients with acute deep venous thrombosis in the lower limbs

    European Journal of Internal Medicine

  6. Incidence and long-term outcomes of upper limb deep vein thrombosis associated with intracardiac devices: analysis of bleeding, recurrence, and sequelae

    Internal and Emergency Medicine, Vol. 19, Núm. 7, pp. 1959-1966

  7. Long-term monitoring and treatment of venous thromboembolism disease: recommendations of venous thromboembolism group of the Spanish Society of Internal Medicine

    Revista Clinica Espanola

  8. Prognostic Significance of Heart Failure in Acute Pulmonary Embolism: A Comprehensive Assessment of 30-Day Outcomes

    Journal of Clinical Medicine, Vol. 13, Núm. 5

  9. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  10. Soluble urokinase type plasminogen activator receptor (suPAR) and mortality in acute pulmonary embolism

    Medicina Clinica, Vol. 163, Núm. 6, pp. 281-285

  11. The Potential Role of CA-125 as a Biomarker for Short-Term Mortality Risk in Patients with Acute Symptomatic Pulmonary Embolism

    Journal of Clinical Medicine, Vol. 13, Núm. 12

  12. The prognostic value of blood cellular indices in pulmonary embolism

    American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711

  13. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

    Blood Advances, Vol. 8, Núm. 18, pp. 4950-4959

2023

  1. A RARE CASE OF STROKE AS A COMPLICATION AFTER PERCUTANEOUS MECHANICAL THROMBECTOMY IN A PATIENT WITH INTERMEDIATE-HIGH RISK PULMONARY EMBOLISM AND PATENT FORAMEN OVALE

    European Journal of Case Reports in Internal Medicine, Vol. 10, Núm. 7

  2. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

    Thrombosis Update, Vol. 13

  3. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7

  4. Cerebral venous thrombosis in adults: A case series of 35 patients from a tertiary hospital

    Revista Clinica Espanola, Vol. 223, Núm. 7, pp. 423-432

  5. Clinical characteristics and presentation form in patients with venous thromboembolism and negative or weakly positive D-dimer

    Medicina Clinica, Vol. 160, Núm. 6, pp. 253-257

  6. Enfermedad tromboembólica venosa: embolia pulmonar aguda

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 88, pp. 5196-5207

  7. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981